Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126
Titel:
Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126
Auteur:
Eppstein, Andrew C. Sandoval, John A. Klein, Patrick J. Woodruff, Heather A. Grosfeld, Jay L. Hickey, Robert J. Malkas, Linda H. Schmidt, C. Max